CAPR - Capricor Therapeutics' (CAPR) CEO Linda Marbán on Q4 2020 Results - Earnings Call Transcript
Capricor Therapeutics, Inc. (CAPR) Q4 2020 Earnings Conference Call March 11, 2021 4:30 PM ET Company Participants AJ Bergmann – Chief Financial Officer Linda Marbán – Chief Executive Officer Stephen Gould – Executive Consultant Conference Call Participants Michael Okunewitch – Maxim Group Emanuela Branchetti – H.C. Wainwright Alan Leong – BioWatch News Presentation Operator Greetings, and welcome to Capricor Therapeutics Fourth Quarter Full Year 2020 Earnings and Corporate Update Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, AJ Bergmann, Chief Financial Officer. Mr. Bergmann, are you muted? AJ Bergmann Yes. Thank you very much. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include
For further details see:
Capricor Therapeutics' (CAPR) CEO Linda Marbán on Q4 2020 Results - Earnings Call Transcript